Determination of Selected Chemical Levels in Room air and on Surfaces after the Use of Cartridge- and Tank-Based E-Vapor Products or Conventional Cigarettes
Individual Clinical
Respiratory Toxicity
Liu (2017)
arsenic species in electronic cigarettes: Determination and potential health risk.
Nonclinical
Chemical
Analysis
Liu (2020)
Metabolomic analysis Identified Reduced Levels of Xenobiotics, Oxidative Stress, and Improved Vitamin Metabolism in Smokers Switched to Vuse Electronic Nicotine Delivery System.
Population Clinical
Population Health Impact
Liu (2021)
Prevalence and Distribution of Electronic Cigarette Use Before and During Pregnancy among Women in 38 States of the United States.
Population Clinical
Consumer Use
Factors Influencing Patterns Of Use
Liu (2021)
Flavored and Nicotine-Containing E-Cigarettes Induce Impaired angiogenesis and Diabetic Wound healing via Increased Endothelial Oxidative Stress and Reduced NO Bioavailability.
Nonclinical
Cytotoxicity
Liu (2022)
Nicotine pharmacokinetics and subjective responses after using nicotine pouches with different nicotine levels compared to combustible cigarettes and moist smokeless tobacco in adult tobacco users.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Liu (2022)
The association between electronic cigarettes, sleep duration, and the adverse cardiovascular outcomes: Findings from behavioral risk factor surveillance system, 2020.
Individual Clinical
Safety
Adverse Effects
Liu (2022)
E-cigarettes Induce Dysregulation of autophagy Leading to Endothelial Dysfunction in Pulmonary arterial hypertension.
Nonclinical
Immunotoxicity
In Vitro
Liu (2023)